A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC)
Clinical trial NCT02913443 · COMPLETED
Trial details
- NCT number
- NCT02913443
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-20
- Primary completion
- 2017-10-24
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.